Search for Clinical Trial Results
Kidney Diseases, Cystic - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Canadian Medical Assessment of JINARC™ Outcomes Registry Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2016-09-30 |
Recruiting |
Study Name: Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease) Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2016-08-30 |
Recruiting |
Study Name: A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2016-07-21 |
Recruiting |
Study Name: Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease Condition: ADPKD Date: 2016-05-04 Interventions: Other: water |
Not yet recruiting |
Study Name: The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2016-04-08 Interventions: Device: Vessix Renal denervation using radio-ablation |
Recruiting |
Study Name: Efficacy of Tolvaptan on ADPKD Patients Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2016-03-11 Interventions: Drug: Tolvaptan |
Recruiting |
Study Name: Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease Condition: Polycystic Kidney Disease Date: 2015-10-30 Interventions:
|
Recruiting |
Study Name: Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease Condition: Polycystic Kidney, Autosomal Dominant Date: 2015-12-23 Interventions:
|
Active, not recruiting |
Study Name: Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101 Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2015-11-24 Interventions: Drug: tesevatinib Other Name: KD019, XL647 |
Recruiting |
Study Name: Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2) Condition: Polycystic Kidney Disease Date: 2015-09-21 Interventions:
|